CSIMarket Company Name, Ticker, Suppliers, else..
 
Impel Pharmaceuticals Inc   (NASDAQ: IMPL)
 

IMPL's Market share relative to its competitors, as of Q3 2023

As of Q3 2023 (Revenue in Millions of $)

Date modified: 2026-05-18T05:36:27+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months
Q3 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE
A Quarter Before
Q2 2023
Impel Pharmaceuticals Inc 8.22 0.06% 0.15 % 0.24 %
Biomarin Pharmaceutical Inc 3,242.32 24.15% 31.51% 28.98%
Neurocrine Biosciences Inc 3,102.40 23.10% 30.54% 30.80%
Adhera Therapeutics Inc 2,732.01 20.35% 0.00% 0.00%
Alkermes Plc 1,562.30 11.63% 15.79% 14.86%
Supernus Pharmaceuticals inc 776.83 5.79% 6.61% 8.00%
22 more competitors available

Sign in to see all competitors for Impel Pharmaceuticals Inc .

Sign In Create Free Account



IMPL's Market share relative to its competitors, as of Q3 2023 within the Major Pharmaceutical Preparations Industry
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Impel Pharmaceuticals Inc 0.08% 0.08% 0.22 % 0.35 %
Biomarin Pharmaceutical Inc 31.40% 39.54% 45.37% 41.87%
Adhera Therapeutics Inc 26.46% 9.86% 0.00% 0.00%
Alkermes Plc 15.13% 18.12% 22.74% 21.47%
Supernus Pharmaceuticals inc 7.52% 8.82% 9.52% 11.56%
Axsome Therapeutics Inc 6.86% 7.84% 10.01% 10.45%
20 more companies available

Sign in to see all industry competitors for Impel Pharmaceuticals Inc .

Sign In Create Free Account



IMPL's Market share relative to its competitors, as of Q3 2023 within the Healthcare Sector
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Impel Pharmaceuticals Inc 0.06% 0.06% 0.15 % 0.24 %
Biomarin Pharmaceutical Inc 24.15% 29.26% 31.51% 28.98%
Neurocrine Biosciences Inc 23.10% 25.99% 30.54% 30.80%
Adhera Therapeutics Inc 20.35% 7.30% 0.00% 0.00%
Alkermes Plc 11.63% 13.41% 15.79% 14.86%
Supernus Pharmaceuticals inc 5.79% 6.53% 6.61% 8.00%
21 more companies available

Sign in to see all sector competitors for Impel Pharmaceuticals Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Impel Pharmaceuticals Inc's market divisions, geographic dispersion, segments, products, and services, visit Impel Pharmaceuticals Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.